TRAF6 and B-cell chronic lymphocytic leukemia: It was found that miR-146 inhibits IRAK1 and TRAF6 genes, inducing endotoxin tolerance, with the inability of monocytes to exert immune function, without any correlation with immunoparalysis or dysimmune status of CLL patients [111].